维普期刊资源整合服务平台（V6.5）

39篇 您的检索式：作者名="BEEREPOOT"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients显示文摘	Beerepoot LV Mehra N Vermaat JSP	2004	Ann Oncol2004，15，1：	1
2	Recombinant human angiostatin by twice-daily subcutaneous injection in advanced cancer:a pharmacokinetic and long-term safety study显示文摘	LAURENS V BEEREPOOT	2003	Clin Cancer Res2003，9，11：	1
3	Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patient 显示文摘	Beerepoot LV Mehra N Vemaat JS	2004	Ann Oncol2004，15，1：	1
4	Public energy performance policy and the effect on diffusion of solar thermal systems in buildings : A Dutch experience 显示文摘	BEEREPOOT M	2007	Renewable energy2007，32，11：	1
5	Trastuzumab and bevacizumab combined with docetaxel,oxaliplatin and capecitabine as firstline treatment of advanced HER-2-positive gastric cancer:a multicenter phase II study显示文摘	Meulendijks D Beerepoot LV Boot H	2016	Investigational New Drugs2016，34，：	1
6	Government regulation as an im- petus for innovation: Evidence from energy performance regulation in the Dutch residential building sector 显示文摘	BEEREPOOT M BEEREPOOT N	2007	Energy Policy2007，，35：	1
7	Increased levels of viable circulation cells are an indicator of progressive disease in cancer patients显示文摘	Mehra N Vemat J S	2004	Ann Oncol2004，15，1：	1
8	Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients显示文摘	Beerepoot LV Mehra N Vermaat JS	2004	Ann Oncol2004，15，1：	1
9	Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients显示文摘	BEEREPOOT LV MEHRA N VERMAAT JS	2004	Ann Oncol2004，15，：	1
10	Phase I pharmacokinetic and pharmacodynamic study of the oral protein kinase C beta-inhibitor enzastaurin in combination with gemcitabine and cisplatin in patients with advanced cancer 显示文摘	Rademaker-Lakhai JM Beerepoot LV Mehra N	2007	Clin Cancer Res2007，13，：	1
11	Increased levels of viable circtdating endothelial cells are an indicator cancer progressive disease in cancer patients 显示文摘	Beerepoot LV	2004	Ann Oncol2004，15，：	1
12	Increased levels of viable circulating endothelial cells are an indicator of progressive disease m cancer patients显示文摘	Beerepoot LV Mehra W Vermaat JS	2004	Ann Oncol2004，15，1：	1
13	Government Regulation as an Impetus for Innovation: Evidence from Energy Performance Regulation in the Dutch Residential Building Sector显示文摘	Milou Beerepoot Niels Beerepoot	2007	Energy Policy2007，，10：	1
14	Phase I clinical evaluation of weekly administration of the novel vascular-targeting agent, ZD6126, in patients with solid tumors 显示文摘	Beerepoot LV Radema SA Witteveen EO	2006	J Clin 0ncol2006，24，10：	1
15	Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients显示文摘	Beerepoot LV Mehra N Vermaat JS et at	2004	Ann Oncol2004，15，：	1
16	Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo显示文摘	Kuroki M Voest EE Amano S Beerepoot LV Takashima S Folentino M	1996	J Clin Invest1996，98，7：	1
17	Government regulation as an impetus for innovation: Evidence from energy performance regulation in the Dutch residentiM building sector显示文摘	Beerepoot M Beerepoot N	2007	Energy Policy2007，35，10：	1
18	Nonantibiotic prophylaxis for recurrent urinary tract infections:a systematic review and meta-analysis of randomized controlled trials显示文摘	BEEREPOOT MJ GEERLINGS SE HAARST EV	2013	J Urol2013，190，6：	1
19	Nonantibiotic prophylaxis for recurrent urinary tract infections: a systematic review and meta-analysis of randomized controlled trials 显示文摘	Beerepoot MAJ Geerlings SE van Haarst EP	2013	J Urol2013，190，6：	1
20	Increased levels of viable of circulating endothelial cells are an indicator of progressive disease in cancer patients显示文摘	Beerepoot LV Mehra N Vermaat JS	2004	Ann Oncol2004，15，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示